Efficacy and safety of the oral direct thrombin inhibitor ximelagatran compared with current standard therapy for acute, symptomatic deep vein thrombosis, with or without pulmonary embolism: The THRIVE treatment study. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Francis, CW
  • Ginsberg, Jeffrey
  • Berkowitz, SD
  • Bounameaux, H
  • Davidson, BL
  • Eriksson, H
  • Fiessinger, JN
  • Huisman, MV
  • Lundstrom, T
  • Nystrom, P

publication date

  • November 16, 2003

published in